AQR Capital Management - CATABASIS PHARMACEUTICALS IN ownership

CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 64 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$66,000
-37.1%
31,393
-13.9%
0.00%
Q1 2021$105,000
-59.5%
36,458
-69.8%
0.00%
Q4 2020$259,000120,8370.00%
Other shareholders

There were no reported owners of CATABASIS PHARMACEUTICALS IN in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CATABASIS PHARMACEUTICALS IN shareholders